Form 8-K - Current report:
SEC Accession No. 0000890163-06-000782
Filing Date
2006-12-01
Accepted
2006-12-01 16:32:47
Documents
5
Period of Report
2006-11-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s11-6884_8k.htm 8-K 14369
2 EXHIBIT 4.1 s11-6884_ex41.htm EX-4 54587
3 EXHIBIT 10.1 s11-6884_ex101.htm EX-10 160207
4 EXHIBIT 99.1 s11-6884_ex991.htm EX-99 17791
5 GRAPHIC img1.jpg GRAPHIC 6356
  Complete submission text file 0000890163-06-000782.txt   257498
Mailing Address 1220 GLENMORE DRIVE APOPKA FL 32712
Business Address 1220 GLENMORE DRIVE APOPKA FL 32712 407-880-2213
SHEFFIELD PHARMACEUTICALS INC (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 061251673
SIC: 6770 Blank Checks